Saudi Journal of Pathology and Microbiology (SJPM)
Volume-3 | Issue-09 | 286-290
Original Research Article
Cognitive Impairement among Hemodialysis Patients: A Moroccan Study
B.A, Chouhani, S Lamrani, N. Ech chouiyekh,F.Diallo, A Chrifi Alaoui, C.Elmaaroufi, N. Kabbali, C. Nejjari, M Er rassfa, T. Sqalli
Published : Sept. 30, 2018
Abstract
In Morocco, the number of people aged 60 and over has increased. This
draws attention to conditions whose prevalence increases with age including chronic
kidney failure and dementia. This population appears to have a higher risk of cognitive
impairment. The aim of our study is to determine the prevalence of cognitive disorders
in our dialyzed patients, to define the types of this decline and identify the factors
associated with cognitive decline. Observational, cross-sectional study of 116 patients
taking hemodialysis from El Ghassani hemodialysis center in Fez. We used the
Montreal cognitive assessement test before the hemodialysis session, A Moca ≤ 24/30
indicate the presence of cognitive impairment. The Moca was abnormal in 70% of our
patients. The average score was lower for women. The areas most affected were
attention and short-term memory. We found a strong correlation between the decrease
in the Moca score and the progression in age (p <0.001). Hypertension was correlated
with a Moca score with an average score in the hypertensive population of 20 ± 5.4 (p
<0.006). The relationship between cardiac disease and Moca was significant with an
average score in patients with heart disease of 19 (p <0.01). Taking an erythropoiesisstimulating agents were linked to the Moca test (p <0.05). The number of sessions per
week was significantly correlated with Moca (r: 0.25, p <0.005). Albumin and
hemoglobinemia were correlated with the Moca score (r: 0.2, p <0.027) and (r: 0.2, p
<0.02) respectively.